Factors associated with microalbuminuria in non-hypertensive type-2 diabetes patients

被引:0
作者
Lopez-Arce, Gustavo
Espinoza-Peralta, Diego
Hernandez-Alarcon, Adriana
Alejandro Arce-Salinas, C.
机构
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2008年 / 60卷 / 01期
关键词
diabetic nephropathy; renal insufficiency; high blood pressure; caloric intake; overweight;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Microalbuminuria is a well known risk factor for renal damage and for cardiovascular disease in type-2 diabetic patients. Objective. To evaluate anthropometric, laboratory, and diet factors related to the presence of microalbuminuria in non-hypertensive type 2 diabetic subjects. Material and methods. We carry-out an assessment of a group of nonhypertensive diabetic patients with or without microalbuminuria. Some anthropometric measures, physical fitness, tobacco and alcohol consumption, creatinine clearance, HbAc, lipid profile, the mean fast serum glucose levels in last two years, 24 h urine protein, and caloric intake were all measured. Results. From 86 included patients, 19 had microalbuminuria; it was related with the length of diabetes mellitus duration (114 +/- 55 vs. 84 +/- 67 months; p = 0.03), higher HbA(1)c level (8.9 vs. 7.1%; p = 0.001), and lower HDL-cholesterol levels (37.7 +/- 11 vs. 42.9 +/- 12 mg/dL; p = 0.03). In the multivariate analysis HbAc level, and mean fast glucose remained significant. Conclusions. In non-hypertensive diabetic subjects, poor glucose control, and longer disease duration were both related with microalbuminuria. Moreover, caloric intake, exercise, tobacco or alcohol consumption, or BMI did not show association with microalbuminuria.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 44 条
[1]   Characteristics of patients with type 2 diabetes in Mexico -: Results from a large population-based nationwide survey [J].
Aguilar-Salinas, CA ;
Monroy, OV ;
Gómez-Pérez, FJ ;
Chávez, AG ;
Esqueda, AL ;
Cuevas, VM ;
Rull-Rodrigo, JA ;
Conyer, RT .
DIABETES CARE, 2003, 26 (07) :2021-2026
[2]  
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[3]   Chronic kidney disease in the developing world [J].
Barsoum, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :997-999
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]   Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes [J].
Colhoun, HM ;
Lee, ET ;
Bennett, PH ;
Lu, M ;
Keen, H ;
Wang, SL ;
Stevens, LK ;
Fuller, JH .
DIABETOLOGIA, 2001, 44 (Suppl 2) :S46-S53
[6]   Targets to retard the progression of diabetic nephropathy [J].
Cooper, ME ;
Jandeleit-Dahm, K ;
Thomas, MC .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1439-1445
[7]   Microalbuminuria as a predictor of myocardial infarction in a Mexican population: The Mexico City Diabetes Study [J].
Corona, AJ ;
Martinez, DR ;
Avila, MH ;
Haffner, S ;
Williams, K ;
Villalpando, MEG ;
Simon, J ;
Stern, M ;
Gonzalez-Villalpando, C .
KIDNEY INTERNATIONAL, 2005, 68 :S34-S39
[8]   Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus [J].
Cueto-Manzano, AM ;
Cortes-Sanabria, L ;
Martinez-Ramirez, HR ;
Rojas-Campos, E ;
Barragan, G ;
Alfaro, G ;
Flores, J ;
Anaya, M ;
Canales-Munoz, JL .
KIDNEY INTERNATIONAL, 2005, 68 :S40-S45
[9]  
Deferrari G, 1998, NEPHROL DIAL TRANSPL, V13, P11
[10]  
Deferrari G, 1997, DIABETES METAB REV, V13, P51